5.2018
Precedente Chiudi:
$5.05
Aprire:
$5
Volume 24 ore:
3,107
Relative Volume:
0.03
Capitalizzazione di mercato:
$6.50M
Reddito:
-
Utile/perdita netta:
$-7.03M
Rapporto P/E:
-0.5836
EPS:
-8.9134
Flusso di cassa netto:
$-8.20M
1 W Prestazione:
+3.96%
1M Prestazione:
-17.97%
6M Prestazione:
-21.52%
1 anno Prestazione:
+62.54%
Endra Life Sciences Inc Stock (NDRA) Company Profile
Nome
Endra Life Sciences Inc
Settore
Industria
Telefono
734-335-0468
Indirizzo
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, WAT, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
NDRA
Endra Life Sciences Inc
|
5.235 | 6.27M | 0 | -7.03M | -8.20M | -8.9134 |
|
TMO
Thermo Fisher Scientific Inc
|
442.24 | 162.90B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
163.92 | 114.60B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
546.47 | 41.71B | 4.45B | 1.10B | 1.06B | 13.59 |
|
WAT
Waters Corp
|
336.43 | 32.32B | 3.77B | 449.25M | 240.68M | 7.8556 |
|
A
Agilent Technologies Inc
|
113.36 | 31.57B | 7.07B | 1.29B | 993.00M | 4.5355 |
Endra Life Sciences Inc Borsa (NDRA) Ultime notizie
NDRA Strengthens Clinical Foundation for TAEUS Liver Technology - GuruFocus
ENDRA liver scan aligns with MRI as liver disease SLD affects 30% of adults - Stock Titan
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) faces Nasdaq equity notice after Q1 loss - Stock Titan
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - The Chronicle-Journal
ENDRA Life (NDRA) Q4 2025 Results Miss Estimates — EPS $-3.26 vs $-1.25Crowd Trend Signals - newser.com
NDRA Q1'26 Earnings: EPS estimate is (1.23) USD - TradingView
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Endra Life Sciences (NDRA) Achieves Promising Results with TAEUS Liver - GuruFocus
Endra Life Sciences reports multi-site validation of TAEUS Liver device - TipRanks
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accu - PharmiWeb.com
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - BioSpace
ENDRA reports multi-site validation results for liver imaging device - Investing.com UK
ENDRA reports multi-site validation results for liver imaging device By Investing.com - Investing.com Australia
TradingKey - TradingKey
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play - openPR.com
Is ENDRA Life (NDRA) stock suitable for your portfolio? (Nudges Down) 2026-04-27Senior Analyst Forecasts - Newser
ENDRA Life Sciences (NDRA) price target decreased by 10.00% to 27.54 - MSN
ENDRA Life (NDRA) Stock Chart | Q4 2025: Earnings Fall ShortFree Cash Margin - Xã Châu Thành
ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk - The Globe and Mail
ENDRA Life Sciences Inc. Files Form 8-K with SEC – Company Details, Address, and Compliance Information (April 2026) 23 - Minichart
Endra Life Sciences receives Nasdaq delisting notice over equity requirement - Investing.com
ENDRA Life Sciences Received Notice of Delisting - TradingView
Equity shortfall puts ENDRA Life Sciences (NASDAQ: NDRA) at renewed Nasdaq delisting risk - Stock Titan
ENDRA Life (NDRA) Stock: Price Action (Declines) 2026-04-20Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
ENDRA Life (NDRA) Stock Strangle (Overhead Buying) 2026-04-15Crowd Entry Signals - newser.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Barchart.com
Aug Fed Impact: What is the PEG ratio of ENDRA Life Sciences IncMarket Movers & Fast Momentum Entry Tips - baoquankhu1.vn
Is ENDRA Life (NDRA) Stock Good for Portfolio | Price at $4.95, Down 6.78%Sector Leader - newser.com
Aug Fed Impact: Whats the MACD signal for ENDRA Life Sciences IncGDP Growth & Long-Term Safe Investment Ideas - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Is ENDRA Life (NDRA) Stock Near Resistance | Price at $5.10, Down 4.49%AI Stock Signals - newser.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside - Barchart
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 - openPR.com
Retail Surge: Is ENDRA Life Sciences Inc exposed to currency risks2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView — Track All Markets
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
ENDRA Life Sciences | 8-K: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Moomoo
ENDRA Life Sciences Q4 net loss narrows - TradingView — Track All Markets
Form 8-KCurrent report - ADVFN
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - ChartMill
Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
ENDRA Life Sciences (NDRA) Expected to Announce Earnings on Monday - National Today
Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):